HMGB1 and epilepsy: Besides confirming the mechanistic importance of HMGB1, these increased serum and cerebrospinal fluid levels in patients with epilepsy and depression suggest its potential as a biomarker for disease severity, prognosis, and even as a measure to monitor the success of new anti-inflammatory therapies for these debilitating conditions [36].